Cargando…
Acquired Clotting Factor Deficits During Treatment with Asparaginase in an Institutional Cohort
We invariably see prolongation of activated partial thromboplastin time in patients treated with asparaginase in our clinical practice, but have noted that, contrary to hypofibrinogenemia and low antithrombin, clotting times’ prolongation by asparaginase is largely unreported in the literature and g...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641023/ https://www.ncbi.nlm.nih.gov/pubmed/37965639 http://dx.doi.org/10.2147/JBM.S428159 |